The LightMix Ebola Zaire rRT-PCR Test from pharmaceutical company Roche will test for the strain of Ebola behind the current outbreak, called Zaire, and can be completed in around three hours.
Although the test is not yet FDA-approved for general use, the FDA’s Emergency Use Authorization will allow select laboratories in the United States and other countries to use the test for the Ebola Zaire strain until the outbreak is under better control, according to the report.
More articles on Ebola:
Confirmed Ebola case in Scotland
7 lessons learned from the Ebola outbreak
CDC lab tech exposed to Ebola showing no signs of disease
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.